Exhibit 99.1 Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results - Establishes Fiscal 2023 Guidance - PIOMBINO DESE, Italy – March 2, 2023 – Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and full year 2022, and established fiscal 2023 guidance. Fourth Quarter and Full Year 2022 ...